首页8QQ • FRA
add
AbCellera Biologics Inc
昨日收盘价
€1.78
当日价格范围
€1.78 - €1.78
年度波幅
€1.70 - €3.79
市值
5.88亿 USD
平均交易量
448.00
市盈率
-
股息率
-
主要交易所
NASDAQ
市场资讯
财务信息
损益表
收入
净收入
| (USD) | 2025年3月info | 年同比变化 |
|---|---|---|
收入 | 423.50万 | -57.45% |
经营支出 | 2439.90万 | -4.55% |
净收入 | -4562.10万 | -12.34% |
净利润率 | -1077.24 | -164.04% |
每股收益 | -0.15 | -7.14% |
息税折旧摊销前利润 | -5732.90万 | -14.54% |
有效税率 | 13.90% | — |
资产负债表
总资产
负债总额
| (USD) | 2025年3月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 6.05亿 | -13.29% |
总资产 | 13.44亿 | -8.13% |
负债总额 | 3.21亿 | -3.59% |
权益总额 | 10.23亿 | — |
发行在外的股份 | 2.98亿 | — |
市净率 | 0.52 | — |
资产回报率 | -11.58% | — |
资本回报率 | -14.16% | — |
现金流
现金净变动
| (USD) | 2025年3月info | 年同比变化 |
|---|---|---|
净收入 | -4562.10万 | -12.34% |
来自运营的现金 | -1155.40万 | 72.30% |
投资现金 | 793.50万 | -73.47% |
融资现金 | 597.00万 | 110.88% |
现金净变动 | 294.10万 | 130.17% |
自由现金流 | -6359.55万 | -21.59% |
简介
AbCellera Biologics Inc. is a Vancouver, British Columbia-based contract research organization that is contracted by biotechnology and pharmaceutical companies for antibody services, and researches and develops human antibodies as a service for its clients. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
CEO
成立时间
2012
员工数量
596
